Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Carolyn Jacob

Dermatology Chicago, IL Medical Doctor

NPI 1265498083 CMS profile 239338

515 N State St Ste 900, Chicago, IL 60654

Open in the dashboard

General payments

$566,295

1,068 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$40,179 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Carolyn Jacob of Chicago, IL is reported in the CMS Open Payments database as having received $566,295 across 1,068 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $40,179 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $66,377 128
2024 General $49,690 97
2023 General $71,168 135
2022 General $95,087 150
2021 General $88,815 190
2020 General $60,377 107
2019 General $134,781 261

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carolyn Jacob
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Carolyn Jacob were reported at $66,377. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Carolyn Jacob Dermatology median Middle half National median
2019 $134,781 $454 $129–$1,240 $163
2020 $60,377 $235 $81–$756 $114
2021 $88,815 $377 $108–$1,108 $132
2022 $95,087 $514 $143–$1,391 $149
2023 $71,168 $607 $159–$1,674 $160
2024 $49,690 $751 $204–$1,903 $164
2025 $66,377 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $230,080 374 payments
  2. Galderma Laboratories, L.P. $182,360 212 payments
  3. Allergan Inc. $51,646 51 payments
  4. Solta Medical, a division of Bausch Health US, LLC $42,343 23 payments
  5. Dermira, Inc. $14,224 25 payments
  6. Revance Therapeutics, Inc. $10,054 9 payments
  7. Ortho Dermatologics, a division of Bausch Health US, LLC $9,415 19 payments
  8. Endo Pharmaceuticals Inc. $8,605 10 payments
  9. E.R. Squibb & Sons, L.L.C. $4,657 4 payments
  10. Galderma Research & Development, LLC $2,975 1 payment
  11. Other $9,937 340 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $366,335 122 payments
  2. Consulting Fee $100,659 28 payments
  3. Travel and Lodging $45,157 149 payments
  4. Food and Beverage $31,642 752 payments
  5. Honoraria $11,250 4 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $6,300 2 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $4,785 1 payment
  8. Education $168 10 payments
Products named General payments · program years 2019–2025
  1. SKYRIZI Immunology $165,215 208 payments
  2. SKYRIZI Immunology $30,486 24 payments
  3. HUMIRA $23,798 79 payments
  4. CLEAR+BRILLIANT $21,916 7 payments
  5. QBREXZA $14,143 20 payments
  6. DAXXIFY $10,054 9 payments
  7. ALTRENO $7,758 10 payments
  8. RINVOQ $4,801 42 payments
  9. BOTOX $2,739 42 payments
  10. SOFDRA $1,097 7 payments
  11. Other $9,894 481 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$21,968

Medicare's payments for the services billed

Medicare patients

104

Average age 73

Services billed

368

79 women, 25 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 47%
Arthritis 40%
Osteoporosis 22%
Cancer 14%
Ischemic heart disease 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 16 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
$20,942 — —
DAXXIFY
$9,459 — —
RINVOQ
$253 — —
BOTOX
$179 — —
Bimzelx
$121 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 16 in the dashboard with a free account

Records

1,068 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record